Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,737,802
+$132,396 QoQ
Shares Held
10,322
+0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#967
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. AMGN ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
This page
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,737,802 | 10,322 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,605,406 | 10,247 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,353,945 | 10,247 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,891,703 | 10,247 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,847,104 | 10,197 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,176,875 | 10,197 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,651,230 | 10,172 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,277,520 | 10,172 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,178,241 | 10,172 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,870,779 | 10,097 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,898,345 | 10,063 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,704,531 | 10,063 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,234,187 | 10,063 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,432,730 | 10,063 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,642,946 | 10,063 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,868,115 | 8,288 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,016,470 | 8,288 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,004,204 | 8,288 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,864,551 | 8,288 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,762,443 | 8,288 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,971,450 | 8,088 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,012,375 | 8,088 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,931,557 | 8,401 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,135,198 | 8,401 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,981,459 | 8,401 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,703,134 | 8,401 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||